These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

713 related items for PubMed ID: 15146410

  • 1. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
    Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R, Bekker P, 20000223 Study Group.
    Arthritis Rheum; 2004 May; 50(5):1412-9. PubMed ID: 15146410
    [Abstract] [Full Text] [Related]

  • 2. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D.
    Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
    Weinblatt ME, Schiff MH, Ruderman EM, Bingham CO, Li J, Louie J, Furst DE.
    Arthritis Rheum; 2008 Jul; 58(7):1921-30. PubMed ID: 18576334
    [Abstract] [Full Text] [Related]

  • 4. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ.
    N Engl J Med; 1999 Jan 28; 340(4):253-9. PubMed ID: 9920948
    [Abstract] [Full Text] [Related]

  • 5. Anakinra: new preparation. Weakly effective in rheumatoid arthritis.
    Prescrire Int; 2004 Apr 28; 13(70):43-5. PubMed ID: 15148945
    [Abstract] [Full Text] [Related]

  • 6. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
    Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ, Hanrahan PS, Kraishi MM, Patel A, Sun G, Bear MB, 990145 Study Group.
    Ann Rheum Dis; 2004 Sep 28; 63(9):1062-8. PubMed ID: 15082469
    [Abstract] [Full Text] [Related]

  • 7. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
    Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ.
    Arthritis Rheum; 2003 Jun 28; 48(6):1493-9. PubMed ID: 12794815
    [Abstract] [Full Text] [Related]

  • 8. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Keystone EC, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ.
    Arthritis Rheum; 2004 Feb 28; 50(2):353-63. PubMed ID: 14872476
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Martin Mola E, Pedersen R, Robertson D, Chang D, Koenig A, Freundlich B, Etanercept Study Investigators.
    Ann Rheum Dis; 2009 Jul 28; 68(7):1113-8. PubMed ID: 18718986
    [Abstract] [Full Text] [Related]

  • 10. Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events.
    Yazici Y, Erkan D, Paget SA.
    Arthritis Rheum; 2003 Oct 28; 48(10):2769-72. PubMed ID: 14558081
    [Abstract] [Full Text] [Related]

  • 11. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb 28; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 12. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H, Mayer PR, Wajdula J, Fatenejad S.
    J Clin Pharmacol; 2004 Nov 28; 44(11):1235-43. PubMed ID: 15496641
    [Abstract] [Full Text] [Related]

  • 13. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
    Furst DE.
    Clin Ther; 2004 Dec 28; 26(12):1960-75. PubMed ID: 15823761
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
    Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B.
    J Rheumatol; 2006 Feb 28; 33(2):234-43. PubMed ID: 16465653
    [Abstract] [Full Text] [Related]

  • 15. Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.
    Fleischmann RM, Baumgartner SW, Tindall EA, Weaver AL, Moreland LW, Schiff MH, Martin RW, Spencer-Green GT.
    J Rheumatol; 2003 Apr 28; 30(4):691-6. PubMed ID: 12672185
    [Abstract] [Full Text] [Related]

  • 16. Treatment continuation in patients receiving biological agents or conventional DMARD therapy.
    Zink A, Listing J, Kary S, Ramlau P, Stoyanova-Scholz M, Babinsky K, von Hinueber U, Gromnica-Ihle E, Wassenberg S, Antoni C, Herzer P, Kekow J, Schneider M, Rau R.
    Ann Rheum Dis; 2005 Sep 28; 64(9):1274-9. PubMed ID: 15708884
    [Abstract] [Full Text] [Related]

  • 17. Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.
    Moreland LW, Cohen SB, Baumgartner SW, Tindall EA, Bulpitt K, Martin R, Weinblatt M, Taborn J, Weaver A, Burge DJ, Schiff MH.
    J Rheumatol; 2001 Jun 28; 28(6):1238-44. PubMed ID: 11409115
    [Abstract] [Full Text] [Related]

  • 18. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
    Fleischmann RM, Tesser J, Schiff MH, Schechtman J, Burmester GR, Bennett R, Modafferi D, Zhou L, Bell D, Appleton B.
    Ann Rheum Dis; 2006 Aug 28; 65(8):1006-12. PubMed ID: 16396977
    [Abstract] [Full Text] [Related]

  • 19. Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
    Tesser J, Fleischmann R, Dore R, Bennett R, Solinger A, Joh T, Modafferi D, Schechtman J, 990757 Study Group.
    J Rheumatol; 2004 Apr 28; 31(4):649-54. PubMed ID: 15088288
    [Abstract] [Full Text] [Related]

  • 20. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
    van der Heijde D, Klareskog L, Singh A, Tornero J, Melo-Gomes J, Codreanu C, Pedersen R, Freundlich B, Fatenejad S.
    Ann Rheum Dis; 2006 Mar 28; 65(3):328-34. PubMed ID: 16079172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.